BIOMAT Database Logo BIOMAT Database Logo

Lipid-lowering therapy after myocardial infarction: the Bavarian Cholesterol Screening Project. 1998

W O Richter, and P Schwandt

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000960 Hypolipidemic Agents Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. Antihyperlipidemic,Antilipemic,Antilipemic Agents,Antilipemic Drug,Hypolipidemic Agent,Hypolipidemic Drug,Antihyperlipemics,Antihyperlipidemics,Antilipemic Drugs,Antilipemics,Hypolipidemic Drugs,Agent, Hypolipidemic,Agents, Antilipemic,Agents, Hypolipidemic,Drug, Antilipemic,Drug, Hypolipidemic,Drugs, Antilipemic,Drugs, Hypolipidemic

Related Publications

W O Richter, and P Schwandt
[Cholesterol lowering therapy after myocardial infarction. Consequences of the CARE study].
June 1997, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
W O Richter, and P Schwandt
The value of lowering cholesterol after myocardial infarction.
October 1990, The New England journal of medicine,
W O Richter, and P Schwandt
Lipid-lowering therapy after myocardial infarction: is it worth it?
April 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
W O Richter, and P Schwandt
Use of cholesterol-lowering therapy by elderly adults after myocardial infarction.
May 2002, Archives of internal medicine,
W O Richter, and P Schwandt
Editorial: Lipid-lowering drugs after myocardial infarction.
March 1975, Lancet (London, England),
W O Richter, and P Schwandt
Lipid Lowering After Myocardial Infarction: Too Little, Too Late.
October 2023, Journal of the American College of Cardiology,
W O Richter, and P Schwandt
Depression and failure of cholesterol lowering after acute myocardial infarction.
January 2010, Primary care companion to the Journal of clinical psychiatry,
W O Richter, and P Schwandt
[Value of lipid lowering drugs after myocardial infarction: results of the coronary drug project 1975 (author's transl)].
September 1975, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
W O Richter, and P Schwandt
Lipid-lowering therapy and cholesterol levels following acute myocardial infarction: a German study of 5361 patients.
January 2003, European journal of epidemiology,
W O Richter, and P Schwandt
Time for reestablishment of serum lipid lowering after myocardial infarction?
January 1988, Acta medica Scandinavica,
Copied contents to your clipboard!